title: Neutrophilic eccrine hidradenitis masquerading as facial cellulitis.
abstract: Neutrophilic eccrine hidradenitis typically manifests as erythematous plaques on the face, trunk, or extremities. This eruption has been associated with numerous factors, but most commonly is seen with chemotherapy, particularly cytarabine. We report a 73-year-old woman with acute myelogenous leukemia who developed rapidly expansive neutrophilic eccrine hidradenitis mimicking facial cellulitis only after a course of cytarabine was followed by granulocyte-colony stimulating factor. Prompt diagnosis is imperative to prevent prolonged antimicrobial therapy.
authors.affiliation: Ronald O. Perelman Department of Dermatology, New York University School of Medicine, NY 10016, USA.
authors.forename: Monika
authors.initials: M
authors.lastname: Srivastava
authors.forename: Susan
authors.initials: S
authors.lastname: Scharf
authors.forename: Shane A
authors.initials: SA
authors.lastname: Meehan
authors.forename: David
authors.initials: D
authors.lastname: Polsky
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001707:Biopsy, Needle; D002481:Cellulitis / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology*; D003561:Cytarabine / Q000009:adverse effects* / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000139:chemically induced / Q000175:diagnosis / Q000473:pathology*; D005260:Female; D005500:Follow-Up Studies; D016575:Hidradenitis / Q000139:chemically induced* / Q000175:diagnosis / Q000473:pathology*; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects / Q000627:therapeutic use; D007150:Immunohistochemistry; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment
chemical_list: D003561:Cytarabine; D015255:Idarubicin